Siegfried J M
Department of Pharmacology, University of Pittsburgh, University of Pittsburgh Cancer Institute, PA 15261, USA.
Lancet Oncol. 2001 Aug;2(8):506-13. doi: 10.1016/S1470-2045(01)00457-0.
Smoking-related disease remains a major public-health problem. Large numbers of women continue to smoke, and new smokers are almost as likely to be female as male. Lung cancer is still a largely incurable disease; annual lung-cancer mortality in women exceeds that of breast cancer, and lung cancer now accounts for 12% of all new female cancer cases. The results of several studies suggest that women are more susceptible than men to lung cancer and to conditions that predispose to this cancer, such as chronic obstructive pulmonary disease. There is still much controversy about whether there is an increased lung-cancer risk in women across all populations. Many epidemiological studies have been negative or equivocal when comparing male and female lung-cancer risk. This article is not intended to be a comprehensive review of all epidemiological studies, or of all possible lung-cancer risk factors. Lung-cancer incidence and risk in women are discussed, and evidence for possible mechanisms of increased female risk are presented, including the role of oestrogen in the development of lung cancer.
吸烟相关疾病仍然是一个重大的公共卫生问题。大量女性继续吸烟,而且新吸烟者中女性与男性的比例几乎相同。肺癌在很大程度上仍是一种无法治愈的疾病;女性每年的肺癌死亡率超过乳腺癌,且肺癌目前占所有新增女性癌症病例的12%。多项研究结果表明,女性比男性更容易患肺癌以及易引发这种癌症的疾病,如慢性阻塞性肺疾病。对于所有人群中的女性患肺癌风险是否增加仍存在很多争议。在比较男性和女性患肺癌风险时,许多流行病学研究结果为阴性或不明确。本文并非旨在全面综述所有流行病学研究或所有可能的肺癌风险因素。文中讨论了女性肺癌的发病率和风险,并阐述了女性风险增加可能机制的证据,包括雌激素在肺癌发生中的作用。